학술논문

Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
Document Type
article
Source
International Journal of Molecular Sciences. 24(2)
Subject
Biochemistry and Cell Biology
Biological Sciences
Medicinal and Biomolecular Chemistry
Chemical Sciences
Microbiology
Autoimmune Disease
Transplantation
Cancer
2.1 Biological and endogenous factors
Aetiology
Inflammatory and immune system
Humans
T-Lymphocytes
Regulatory
Autoimmune Diseases
Autoimmunity
Skin Neoplasms
Skin Diseases
Forkhead Transcription Factors
T-regulatory cells
autoimmunity
T effector cells
skin
inflammation
homeostasis
immune suppression
transplantation
cancer
Other Chemical Sciences
Genetics
Other Biological Sciences
Chemical Physics
Biochemistry and cell biology
Medicinal and biomolecular chemistry
Language
Abstract
Regulatory T cells (Tregs) play an important role in maintaining immune tolerance and homeostasis by modulating how the immune system is activated. Several studies have documented the critical role of Tregs in suppressing the functions of effector T cells and antigen-presenting cells. Under certain conditions, Tregs can lose their suppressive capability, leading to a compromised immune system. For example, mutations in the Treg transcription factor, Forkhead box P3 (FOXP3), can drive the development of autoimmune diseases in multiple organs within the body. Furthermore, mutations leading to a reduction in the numbers of Tregs or a change in their function facilitate autoimmunity, whereas an overabundance can inhibit anti-tumor and anti-pathogen immunity. This review discusses the characteristics of Tregs and their mechanism of action in select autoimmune skin diseases, transplantation, and skin cancer. We also examine the potential of Tregs-based cellular therapies in autoimmunity.